1245649-64-2 Usage
Uses
Used in Pharmaceutical Industry:
1-m-tolyl-1H-1,2,4-triazole-3-carboxylic acid is used as a key component in the development of new drugs due to its potential antibiotic, antifungal, and antitumor properties. Its complex structure and the versatility of the triazole nucleus make it a promising candidate for creating novel pharmaceutical compounds.
Used in Chemical Research:
1-m-tolyl-1H-1,2,4-triazole-3-carboxylic acid is used as a research compound in chemical studies, where its unique structure and properties can be explored for potential applications in various chemical reactions and processes. 1-m-tolyl-1H-1,2,4-triazole-3-carboxylic acid's stability and strength contribute to its value in advancing the understanding of triazole-based chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1245649-64-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,5,6,4 and 9 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1245649-64:
(9*1)+(8*2)+(7*4)+(6*5)+(5*6)+(4*4)+(3*9)+(2*6)+(1*4)=172
172 % 10 = 2
So 1245649-64-2 is a valid CAS Registry Number.
1245649-64-2Relevant academic research and scientific papers
NOVEL COMPOUNDS
-
Paragraph 0228; 0229; 0230; 0231; 0232, (2013/06/28)
This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. R1, R2, R3, R4, Q have meanings given in the description.
PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS
-
Page/Page column 52; 53, (2013/07/05)
This invention relates to compounds of formula (I) their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. R1, R2, R3, R4, Q have meanings given in the description.
